Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Analytical and Bioanalytical Chemistry|October 19, 2010
Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectraQingda Zang, David A Keire, Richard D Wood, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 29, 2017
Application of 2D-NMR with room temperature NMR probes for the assessment of the higher order structure of filgrastimRobert G Brinson, Houman Ghasriani, Derek J Hodgson, et al.
The AAPS Journal|April 22, 2022
International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing MedicinesDavid A Keire, Robert Bream, Uwe Wollein, et al.
Biochemical and Biophysical Research Communications|August 15, 2006
Crucial role of position 40 for interactions of CCK-58 revealed by sequence of cat CCK-58Joseph R Reeve, Grace L Rosenquist, David A Keire, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 7, 2013
Characterization of currently marketed heparin products: key tests for LMWH quality assuranceHongping Ye, Timothy K Toby, Cynthia D Sommers, et al.
Mutagenesis|February 23, 2026
Mutagenicity of N-nitroso-fluoxetine and N-nitroso-varenicline in human HepaRG cell modelsJi-Eun Seo, Hannah Xu, Javier Revollo, et al.
Regulatory Peptides|April 11, 2003
Synthesis of biologically active canine CCK-58Joseph R Reeve, David A Keire, Tamer Coskun, et al.
Analytical Biochemistry|August 18, 2015
Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparinDaniel J Mans, Hongping Ye, Jamie D Dunn, et al.
Regulatory Peptides|May 27, 2008
A new endogenous form of PYY isolated from canine ileum: Gly-extended PYY(1-36)David A Keire, Julian P Whitelegge, Sara Bassilian, et al.
Pageof 8